#medications

#medications

Omalizumab shows promise in treating seasonal allergies by targeting underlying allergic responses rather than merely alleviating symptoms.

Physicians are increasingly using new obesity drugs, signaling their effectiveness and potential impact on health.

Ozempic weight-loss drugs may increase the risk of arthritis and pancreatitis despite their benefits in lowering other health risks.

Millions of Americans on injectable weight loss medications face financial uncertainty as affordable compounded versions are being phased out.

New weight-loss medications are aiming to improve upon existing drugs like Ozempic and Wegovy by offering enhanced benefits and resolving current treatment limitations.

WeightWatchers is pivoting to become an online pharmacy, following the rise of weight-loss medications.

The company's stock has increased since the leadership change, reflecting market response to its new direction.

The long-term use of ADHD stimulant medications poses potential cardiovascular risks that may have been overlooked by the FDA.

ADHD medications' benefits outweigh their minimal effects on blood pressure and heart rate, necessitating careful monitoring.